miLab AI Digital Diagnostic Platform

Organization
Noul Co., Ltd. · South Korea
Solution Type
Ready Product / Solution
Collaboration
Business Collaboration (Joint Venture), Licensing

1. Technology overview

Noul Co., Ltd. is a medical diagnostics company established in 2015 and headquartered in Yongin, Gyeonggi-do, South Korea. It develops AI-based digital microscopy so that blood, malaria and cervical cell tests can be read at the point of care without a specialist pathologist. The company has been listed on KOSDAQ since 2022.

The miLab platform combines a compact staining and imaging device, single-use cartridges and AI analysis software. Three solutions run on it: miLab MAL for malaria, miLab BCM for complete blood count and cell morphology, and miLab CER for cervical cancer cytology. It is sold to hospitals, laboratories and public health programs through distributors, including supply to the Charite university hospital in Germany.

2. Highlighted features & specifications

  • miLab MAL: digital microscope that analyses malaria samples.
  • miLab BCM: automated complete blood count and cell morphology analysis.
  • miLab CER: AI cytology for early detection of cervical cancer.
  • Cartridge workflow: single-use cartridges with SafeFix reagent for staining and clearing.
  • AI reading: expert-level cell classification on captured images.

3. Potential application

Provincial and district hospitals in Vietnam can use miLab CER for cervical cancer screening programs. Clinical laboratories and private clinics can use miLab BCM for blood count with morphology review. Public health programs in malaria-risk areas can deploy miLab MAL.

4. Benefits

  • Brings blood and cervical cell analysis to sites without a specialist pathologist.
  • Single-use cartridges and a compact device simplify laboratory workflow.
  • The cervical solution miLab CER was named in the 2024 WHO-Unitaid report as one of three recommended triage technologies.
  • Holds CE marking, Korean MFDS approval and ISO 13485 certification.

6. Other information

Founded 2015, Yongin, South Korea. KOSDAQ IPO in 2022. CE marking 2021-2022, ISO 13485 in 2018, Korean MFDS approval 2019. Series B USD 13.9 million in 2020. Exclusive distribution with Limbach Group (Germany) in 2024; supply to Charite announced October 2025.

Not ready to connect yet?

Save this solution and come back when you are ready to talk to the provider

Trusted by Our Partners

TechFest VietnamIOM – UN MigrationGIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit)APED – Cục Phát triển doanh nghiệp tư nhân và kinh tế tập thểSIHUB – Startup and Innovation Hub of Ho Chi Minh CityHợp tác Đức (Deutsche Zusammenarbeit)SCE & Investment PromotionStartup Vietnam Foundation (SVF)National Startup Support Center (NSSC)01BoosterQuest VenturesBộ Tài chính (Ministry of Finance)ITPC – HCMC Investment and Trade Promotion CentreJICA – Japan International Cooperation AgencyNational Innovation Center (NIC)UK GovernmentBCG – Boston Consulting GroupHAWEEHeineken VietnamTalentnetMB BankVIREA – Liên chi hội Bất động sản Công nghiệp Việt NamJobTestGlobal Supply Chain Support Fund / Aavishkaar CapitalKDANPSE / JPS – Phúc Sang MinhG-AsiaPacificBlueScopeLPBankUlsan Center for Creative Economy & InnovationĐại học Bách khoa Hà Nội – Trường Điện - Điện tửVINK – Vietnam Innovation Network in KoreaTencent WeStart (Shenzhen)Ulsan CollegeK-StartupFaslinkShinhan Future's LabShinhan SecuritiesShinhan FinanceShinhan BankShinhan Life

Start with the right connection

We make innovation easy to access for every business everywhere. The next deal is you.

Contact Us